ArticleTurkish archives of otorhinolaryngology2025
Turkish Validation and Reliability Study of the Carcinologic Handicap Index for Head and Neck Cancer Patients.
Article in Turkish archives of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to conduct a Turkish validation study of the Head and Neck Carcinologic Handicap Index (CHI) and investigate its effectiveness in assessing morbidity in head-and-neck tumor patients. Methods: The original CHI was translated into Turkish after a language validation study based on international standards. The study included 189 patients. Age, gender, primary tumor location, and tumor-node-metastasis stages were recorded. All patients were asked to complete the CHI form. A total of 37 patients completed the CHI form once more within 15 days to examine temporal stability. A control group was also formed to evaluate the validity of the CHI. Results: The Cronbach's alpha coefficient was 0.898. For temporal validity, the global score showed a statistically significant correlation (p<0.001; r=0.604). There was a statistically significant difference between the global scores of the patient and the control groups (p<0.001). The global score and tumor stage differences were statistically significant (p=0.012). Review of the relationship between the tumor location and the scores showed a statistically significant difference in swallowing (p=0.001), feeding (p=0.001), and hearing (p=0.015). Conclusion: The study adapted the CHI into Turkish and showed that it can be used as a valid and reliable index for the morbidity assessment of head-neck cancer patients. We recommend frequent use of the CHI throughout follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.